Cleveland Clinic

This is your central portal for breaking news, the latest research and important updates from Cleveland Clinic. Bookmark this page and check back often for updates.


What’s on Your Shelf? Recommended Reading in the New Year

Healio Rheumatology, January 2020
Leonard H. Calabrese, DO
Over the past few years in this column, I have occasionally shouted out a book I have read and I have occasionally been rewarded by more than a few…
Cover Story

New use for an old drug: The potential of colchicine in CVD

Cardiology Today, January 2020
Secondary prevention of CVD with colchicine is a major focus for the cardiology community, especially after recent presentations of the COLCOT and…

Researchers uncover ‘novel drug target for glioblastoma’

January 10, 2020
An international study of glioblastoma revealed a cellular pathway that appears to contribute to glioma stem cell spread and proliferation. …
Cover Story

Cancer drug doses: More is not always better

HemOnc Today, December 25, 2019
Historically, the goal of cancer treatment has been to destroy as many cancer cells as possible through chemotherapy or radiation. Guided by this…
In the Journals

Posttransplant survival similar with increased-risk vs. standard-risk donor lungs

December 18, 2019
For patients who underwent lung transplantation, survival rates were comparable between those who received lungs from donors who were considered high…
Guest Editorial

Rheum on the go: Keep up to Date With Podcasts

Healio Rheumatology, December 2019
Adam J. Brown, MD
The pace of new information in health care as well as avenues of receiving that information is rising rapidly. I’m sure you have a bounty of…
Cover Story

Failure of Management: Treatment Gaps at the Root of Dismal Gout Care

Healio Rheumatology, December 2019
Experts might use words like “suboptimal” or “insufficient” to describe gout management in the United States. To be fair…
Meeting News

Adjuvant chemotherapy offers limited benefit for invasive lobular carcinoma

December 13, 2019
SAN ANTONIO — Adjuvant chemoendocrine therapy did not extend survival compared with endocrine monotherapy for patients with invasive lobular…
Meeting NewsPerspective

Neoadjuvant pembrolizumab benefits patients with high-risk triple-negative breast cancer

December 12, 2019
SAN ANTONIO — The addition of pembrolizumab to neoadjuvant chemotherapy and as adjuvant therapy increased pathologic complete response among…
Meeting NewsPerspective

Margetuximab extends survival in relapsed HER2-positive metastatic breast cancer

December 12, 2019
SAN ANTONIO — Margetuximab plus chemotherapy conferred a numerically small but statistically significant PFS and OS compared with trastuzumab…
Meeting NewsPerspective

Tucatinib regimen provides ‘unprecedented’ benefit in heavily pretreated HER2-positive breast cancer

December 11, 2019
SAN ANTONIO — The addition of tucatinib to trastuzumab and capecitabine significantly extended survival among heavily pretreated patients with…
Meeting NewsPerspective

Antibody-drug conjugate provides ‘unprecedented’ benefit in metastatic HER2-positive breast cancer

December 11, 2019
SAN ANTONIO — Trastuzumab deruxtecan conferred durable benefit to women with heavily pretreated HER2-posiive metastatic breast cancer…
Cover Story

In obesity, growing CV risk burden demands cross-specialty collaboration, new solutions

Cardiology Today, December 2019
The prevalence of obesity in the U.S. is rising at an alarming rate, as are its CV consequences, a result of greater consumption of high-calorie…
Meeting NewsPerspective

Minor kidney dysfunction should not preclude African Americans with AML from enrolling on clinical trials

December 7, 2019
ORLANDO — Although abnormal kidney function appeared more common among African American patients with acute myeloid leukemia than their white…

Should there be more focus on the financial relationship itself rather than its disclosure?

HemOnc Today, November 25, 2019
POINT The literature has shown that disclosure does not prevent a conflict of interest or bias. The main concern about conflict of interest is that it…

‘Reproducibility crisis’ in radiation biology research could negatively impact clinical care advances

November 20, 2019
The scientific method is the cornerstone of all scientific advancement. By following clearly outlined methods used during an investigator’s…
Cover Story

HF pharmacotherapy in midst of paradigm shift

Cardiology Today, November 2019
Dramatic results of the recent DAPA-HF and PARAGON-HF trials have prompted the cardiology community to rethink pharmacotherapy for patients with HF…
Pharmacology ConsultPerspective

CV controversy of ADHD medication use in children and adolescents

Cardiology Today, November 2019
Sarah Mehringer, PharmD, BCPS, BCCP; Myaa Lightfoot, PharmD; Katie Liveoak, PharmD, BCPP; Jonathan Bain, PharmD, BCCCP, BCPS (AQ Cardiology)
ADHD affects approximately 11% of school-aged children every year, and this rate continues to rise annually. The primary treatment modality includes…

Cleveland Clinic appoints breast medical oncology director

October 26, 2019
Halle Moore, MD, has been appointed director of breast medical oncology at Cleveland Clinic. Moore also will serve as co-director of the…

Immunoautonomics: Can We Hack the Power of the Autonomic Nervous System?

Healio Rheumatology, October 2019
Leonard H. Calabrese, DO
I am extremely excited to showcase our roundtable on immunoautonomics this month. Our thought leaders — including Mark C. Genovese, MD, David